Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,403.24 -35.41 (-0.42%) Bitcoin USD
66,183.01 -164.72 (-0.25%) CMC Crypto 200
1,350.71 -23.14 (-1.68%)
Pacific Biosciences of California, Inc. (PACB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 596.46M |
| Enterprise value | 965.91M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.85 |
| Price/book (mrq) | 0.92 |
| Enterprise value/revenue | 4.82 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.98 |
| 52-week change 3 | -82.72% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 14.5500 |
| 52-week low 3 | 1.2500 |
| 50-day moving average 3 | 2.7722 |
| 200-day moving average 3 | 6.9480 |
Share statistics
| Avg vol (3-month) 3 | 11M |
| Avg vol (10-day) 3 | 14.27M |
| Shares outstanding 5 | 272.36M |
| Implied shares outstanding 6 | 272.36M |
| Float 8 | 270.9M |
| % held by insiders 1 | 1.85% |
| % held by institutions 1 | 94.56% |
| Shares short (30 Apr 2024) 4 | 52.82M |
| Short ratio (30 Apr 2024) 4 | 4.17 |
| Short % of float (30 Apr 2024) 4 | 22.34% |
| Short % of shares outstanding (30 Apr 2024) 4 | 19.39% |
| Shares short (prior month 28 Mar 2024) 4 | 49.05M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -148.13% |
| Operating margin (ttm) | -209.82% |
Management effectiveness
| Return on assets (ttm) | -10.84% |
| Return on equity (ttm) | -44.28% |
Income statement
| Revenue (ttm) | 200.43M |
| Revenue per share (ttm) | 0.77 |
| Quarterly revenue growth (yoy) | -0.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -282.54M |
| Net income avi to common (ttm) | -296.9M |
| Diluted EPS (ttm) | -1.1400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 561.91M |
| Total cash per share (mrq) | 2.06 |
| Total debt (mrq) | 931.37M |
| Total debt/equity (mrq) | 143.50% |
| Current ratio (mrq) | 9.28 |
| Book value per share (mrq) | 2.38 |
Cash flow statement
| Operating cash flow (ttm) | -240.16M |
| Levered free cash flow (ttm) | -304.23M |
© 2024 Yahoo. All rights reserved.